Dopamine D2/3 Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial

Shinichiro Nakajima, Hiroyuki Uchida, Robert Bies, Fernando Caravaggio, Takefumi Suzuki, Eric Plitman, Wanna Mar, Philip Gerretsen, Bruce G. Pollock, Benoit H. Mulsant, David C. Mamo, Ariel Graff-Guerrero

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'Dopamine D<sub>2/3</sub> Receptor Occupancy Following Dose Reduction Is Predictable with Minimal Plasma Antipsychotic Concentrations: An Open-Label Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences